Women’s Health Specialty CRO Health Decisions to Exhibit and Present at DIA 2018
Durham, North Carolina. Health Decisions, Inc., the full-service clinical research organization of choice for forward-looking biopharma and medical device companies and a leader in women’s health and diagnostics studies, today announced a busy schedule of activities at the 2018 Drug Industry Association Global Annual Meeting in Boston June 24-28. Health Decisions’ executives will participate in a forum on incorporating stakeholder input in protocol development, exhibit in booth #2413 and offer a “text-to-win” giveaway, with a chance for entrants to win a Tory Burch designer tote.
“We look forward to a busy schedule of individual meetings at DIA and are pleased once again to be represented in the program,” said Patrick Phillips, D.Phil., Health Decisions CEO. “Chief Medical Officer Andrea Lukes is chairing a forum on stakeholder input in protocol design with support from Clint Dart, our Senior Director, Biostatistics and Programming. Both have extensive experience in protocol development. Anyone responsible for developing a protocol should attend that forum.”
The forum chaired by Dr. Lukes, session #108, is entitled “From Patients and Advocacy Groups to Operations and Beyond: Obtaining and Incorporating Input from Stakeholders in Protocol Design.” The forum will be held Monday, June 25, 11:00am – 12:00pm. Presenting at the session in addition to Dr. Lukes and Mr. Dart will be Michelle Witkop, DNP, Head of Research, National Hemophilia Foundation. The session will address topics including processes for incorporating input from advocacy groups in study planning and protocol development.
As noted above, Health Decisions will hold a “text-to-win” raffle during DIA 2017 for a Tory Burch tote. DIA attendees are invited to stop by booth #2413 to enter the raffle.
To schedule a meeting with a Health Decisions clinical development expert at DIA 2018 in Boston June 24-28, please contact us.
About Health Decisions
Health Decisions is a full-service CRO offering therapeutic, operational and regulatory excellence for clinical development of drugs, diagnostics, medical devices and combination drug/devices in all areas of women’s health. Based on therapeutic and operational experience and investigator relationships developed in studies conducted over the past 28 years, Health Decisions successfully addresses the challenges of developing diagnostics in all therapeutic areas and drugs and devices in areas including reproductive and sexual health, menopause, pain management, osteoporosis/osteoarthritis, reproductive psychiatry, gynecologic oncology and general gynecology indications. Health Decisions is headquartered in Durham, NC.
# # #
+1 919.967.1111 ext. 520
lhammill @ healthdec.com